Show simple item record

dc.contributor.authorRiquino, Michael R.
dc.contributor.authorPriddy, Sarah E.
dc.contributor.authorHoward, Matthew O.
dc.contributor.authorGarland, Eric L.
dc.date.accessioned2019-09-16T15:47:54Z
dc.date.available2019-09-16T15:47:54Z
dc.date.issued2018-06-06
dc.identifier.citationRiquino, M.R., Priddy, S.E., Howard, M.O., & Garland, E.L. (2018). Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients. Borderline Personality Disorder and Emotion Dysregulation, 5:11. doi: 10.1186/s40479-018-0088-6en_US
dc.identifier.urihttp://hdl.handle.net/1808/29601
dc.description.abstractBackground

Chronic pain is a prevalent condition that causes functional impairment and emotional suffering. To allay pain-induced suffering, opioids are often prescribed for chronic pain management. Yet, chronic pain patients on opioid therapy are at heightened risk for opioid misuse—behaviors that can lead to addiction and overdose. Relatedly, chronic pain patients are at elevated risk for suicidal ideation and suicidal behaviors.

Main body

Opioid misuse and suicidality are maladaptive processes aimed at alleviating the negative emotional hyperreactivity, hedonic hyporeactivity, and emotion dysregulation experienced by chronic pain patients on opioid therapy. In this review, we explore the role of emotion dysregulation in chronic pain. We then describe why emotionally dysregulated chronic pain patients are vulnerable to opioid misuse and suicidality in response to these negative affective states.

Conclusion

Emotion dysregulation is an important and malleable treatment target with the potential to reduce or prevent opioid misuse and suicidality among opioid-treated chronic pain patients.
en_US
dc.publisherBioMed Centralen_US
dc.rightsCopyright © 2018, The Authors. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International license (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectAnhedoniaen_US
dc.subjectChronic painen_US
dc.subjectEmotion dysregulationen_US
dc.subjectOpioid misuseen_US
dc.subjectReinforcementen_US
dc.subjectSuicidalityen_US
dc.titleEmotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patientsen_US
dc.typeArticleen_US
kusw.kuauthorRiquino, Michael R.
kusw.kudepartmentSocial Worken_US
dc.identifier.doi10.1186/s40479-018-0088-6en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Copyright © 2018, The Authors.  This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International license (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as: Copyright © 2018, The Authors. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International license (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.